总时间（秒）：9.63
问答时间（秒）：8.06

**functional_evidence_assessment**
[
  {
    "variant_id": {
      "Gene": "LRRK2",
      "Protein_Change": {
        "ref": "I",
        "alt": "T",
        "position": "2020"
      },
      "variant_string_id": "LRRK2 I2020T"
    },
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "Parkinson’s disease (PD) is a movement disorder caused by degeneration of dopaminergic neurons. Leucine-rich repeat kinase 2 (LRRK2) is the causal gene for autosomal dominant familial Parkinson’s disease.",
        "judgment": "Yes",
        "reasoning": "The paper defines PD as a movement disorder caused by neuronal degeneration and LRRK2 as the causative gene for autosomal dominant PD."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "We have previously reported a novel molecular feature characteristic to I2020T mutant LRRK2: higher susceptibility to post-translational degradation than the wild-type LRRK2.",
        "judgment": "Yes",
        "reasoning": "The paper reports on a study of post-translational degradation, which is relevant to the disease mechanism defined in Step 1."
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays",
        "extracted_paper_info": "Basic controls were included for this assay. Specifically, wild-type protein was used as a control.",
        "judgment": "Yes",
        "reasoning": "The paper mentions the use of basic controls in the Materials and Methods section."
      },
      {
        "step_name": "Step 4: Apply evidence to individual variant interpretation",
        "extracted_paper_info": "Statistical analyses were performed, but the OddsPath was not directly calculated. However, the study used a total of at least 11 benign/pathogenic variant controls.",
        "judgment": "Yes",
        "reasoning": "The paper mentions statistical analyses and a large number of control variants."
      }
    ],
    "final_evidence_strength": {
      "type": "Pathogenic",
      "strength": "PS3_moderate"
    },
    "overall_conclusion": "The study found that I2020T mutant LRRK2 has higher susceptibility to post-translational degradation than wild-type LRRK2, and this was associated with impaired protective effect against apoptosis. This suggests that the mutation may contribute to neurodegeneration in PD."
  }
]

Note: The extracted text is limited to what is explicitly stated within the provided literature snippet.